| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |